Tag Archives: (NVS)

Shear Genius

My barber Charlie has this uncanny ability to diagnose which of his clients are making money in the market just by watching how they tip. Last Thursday, while he was working his magic on what’s left of my hairline, he mentioned how his pharmaceutical rep clients have been tipping like oil sheiks lately. “Something big […]

This Big Pharma’s Grand Divorce Shows Promise

While most corporate breakups end with shareholders reaching for antacids, Novartis (NVS) investors are popping champagne instead. The Swiss pharmaceutical giant’s 2023 divorce from its generics business Sandoz (SDZNY) has transformed the company from a pharmaceutical conglomerate into a focused innovation machine – and the numbers would make even the most jaded among us whistle […]